Influenza-like disease
Conditions
Interventions
Test group:Acupoint application combined with conventional western medicine
Sponsors
Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Conform to the diagnostic criteria for influenza like cases in the Diagnosis and Treatment Plan for influenza (2020); (2) Conform to the diagnostic criteria of the syndrome of external cold and internal heat in traditional Chinese medicine; (3) Have symptoms of fever and sore throat, either or both; The standard of fever is axillary temperature = 38 ?, and the standard of pharyngalgia is pharyngalgia visual analogue score (VAS) = 3 points when swallowing; (4) Time of onset < 72h; (5) Age 18 - 65 (including both ends), gender unlimited; (6) Informed consent of patients, volunteers and signed informed consent form.
Exclusion criteria
Exclusion criteria: (1) Those who meet the diagnostic criteria for severe and critical influenza in the Diagnosis and Treatment Plan for influenza (2020 Edition); (2) In line with the influenza Diagnosis and Treatment Plan (2020 Edition), people at high risk of severe/critical influenza: ? Those with the following diseases or conditions: chronic respiratory system disease, cardiovascular system disease (except hypertension), kidney disease, liver disease, blood system disease, nervous system and neuromuscular disease, metabolic and endocrine system disease, malignant tumor, immune function inhibition, etc; ? Obese people [body mass index (BMI) greater than 30]; ? Pregnant and perinatal women. (3) Influenza-like symptoms caused by other diseases; ? (4) Subjects have received antiviral treatment before entering the study; (5) Subjects were treated with traditional Chinese medicine or proprietary Chinese medicine before enrollment; (6) Subjects who plan to be pregnant or pregnant, lactating or lactating; (7) Subjects with skin lesions on the application site, such as scars and ulcers; (8) Subjects with autonomic nervous dysfunction with abnormal sweat secretion; (9) Psychotic patients; (10) Subjects who are allergic to the known test drug; (11) Subjects who are participating in other clinical trials or receiving similar external treatment intervention.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Antipyretic onset time;Antipyretic time;Time of disappearance of pharyngalgia; | — |
Secondary
| Measure | Time frame |
|---|---|
| Heat disappearance rate;Pharyngeal pain disappearance rate;Incidence rate of progression to severe/critical severe within 5 days;Elimination rate of other symptoms; | — |
Countries
China
Contacts
Public ContactRui Gao
Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine
Outcome results
None listed